Navigation Links
MRSA toxin acquitted: Study clears suspected key to severe bacterial illness

Researchers who thought they had identified the bacterial perpetrator of the often severe disease caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) had better keep looking: Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have exonerated a toxin widely thought to be the guilty party.

Panton-Valentine leukocidin (PVL) is one of many toxins associated with S. aureus infection. Because it can be found in virtually all CA-MRSA strains that cause soft-tissue infections, several research groups previously have proposed that PVL is the key virulence factor.

But new evidence strongly suggests that is not the case. A study led by NIAID researchers at Rocky Mountain Laboratories (RML) in Hamilton, MT, shows that the two major epidemic CA-MRSA strains and the same strains with PVL removed are equally effective at destroying human white blood cells--our primary defense against bacterial infections--and spreading disease. The findings, which appear online in The Journal of Infectious Diseases, are surprising because many scientists had presumed that CA-MRSA uses PVL to target and kill specific white blood cells known as neutrophils.

"The Staphylococcus aureus bacterium is a growing global public health menace because of its rapid spread from hospital settings into communities of healthy people," says NIAID Director Anthony S. Fauci, M.D. "This is an evolving pathogen that in recent decades has developed resistance to common medical treatments and now is finding new mechanisms to spread and cause severe illness."

About 75 percent of CA-MRSA infections are localized to skin and soft tissue and usually can be treated effectively. CA-MRSA strains have enhanced virulence, meaning they can infect otherwise healthy people. One of the biggest problems with CA-MRSA skin infections is that they spread rapidly and have the potential to cause ill
'"/>

Source:NIH/National Institute of Allergy and Infectious Diseases


Page: 1 2 3

Related biology news :

1. Defensins neutralize anthrax toxin
2. Green catalyst destroys pesticides and munitions toxins, finds Carnegie Mellon University
3. Tetanus toxin found to have therapeutic properties
4. Structures of marine toxins provide insight into their effectiveness as cancer drugs
5. Prenatal exposure to marine toxin causes lasting damage
6. UCSD study finds anthrax toxins also harmful to fruit flies
7. Scientists design potent anthrax toxin inhibitor
8. Anthrax inhibitor counteracts toxin, may lead to new therapeutics
9. Scientists reveal how deadly toxin hijacks cells
10. Scientists develop a way to make the deadliest toxin known even more toxic
11. Yale researchers find environmental toxins disruptive to hearing in mammals

Post Your Comments:
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the bare... required to produce a cell that can survive on it...cell, and understand how an entire organism functi...ons that scientists in a partnership between the E...delberg, Germany, and the Centre de Regulacio Genm...
(Date:11/25/2009)...hrelin, a hormone produced in the stomach, may be ...ent of Parkinson,s disease, Yale School of Medicin...ent issue of the Journal of Neuroscience . , Pa...opamine neurons in an area of the midbrain known a...opamine production. Reduced production of dopamin...
(Date:11/25/2009)... Dr. Sarit Larisch, Head of the Cell Death Researc...nt of Biology, has been awarded the prestigious Jo...arch exploring the cause of brain cell damage in P...ch year to scientists in support of innovation and... officially conferred earlier this month at an eve...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Carnitine supplements reverse glucose intolerance in animals 9553 1Carnitine supplements reverse glucose intolerance in animals 9553 2New insights into limb formation 9549 1New insights into limb formation 9549 2Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 54355 1Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 54355 2Lumension Expands Global Footprint and Strengthens Capabilities with the Opening of a New Development Office in Ireland 54355 3
...developed a synthetic wood substitute that may one...nd shrink landfills. , The faux lumber is made fr...in a variety of building materials and perhaps rep...ns of disposable water bottles. , "This is a grea...al need and respect and protect the natural enviro...
...ardiovascular Molecular Imaging , This two-day s... leading-edge research in imaging technology and t...uding imaging of cardiovascular receptors, vascula...pair. , SNM and the International Partnership fo...e meeting devoted to FDA requirements for manufact...
...ls reveal much earlier origins of modern octopuses...ssils. The chances of an octopus corpse surviving ...or to this discovery only a single fossil species ... have legs. , Everyone knows what an octopus is. ...h, the eight arms, suckers, and sack-like body are...
Other Biology News:Stanford researchers develop biodegradable substitutes for wood, plastic bottles and other materials 2Stanford researchers develop biodegradable substitutes for wood, plastic bottles and other materials 3SNM Symposium on Multimodality Cardiovascular Molecular Imaging 2Cretaceous octopus with ink and suckers -- the world's least likely fossils? 2
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced that it has received notice fro...any,s common stock will be,suspended as of Novembe...e,Securities and Exchange Commission, which will r..., unless the company files an appeal to the Nasdaq...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced the approval of all of its,"fir...he District of Delaware,(the "Bankruptcy Court"). ...lief under Chapter 11 of the United States Bankrup... orders issued by the Bankruptcy Court allow the c...
(Date:11/24/2009)...HANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Bio...dministration (SFDA) has approved the,investigatio...n project,(Nodlin), an innovative insulin formulat...olaxy to initiate its first phase I clinical study... of high blood glucose and poor,metabolism. The co...
(Date:11/24/2009)...ary efficacy endpoint has been met for patients wi...cer, , QUEBEC CITY, Nov. 24 /PRNewswire-First...: AEZ) (the "Company"), a global biopharmaceutical..., today announced positive efficacy data from a Ph...njugate, AEZS-108 (formerly AN-152), in patients w...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...y Subjects with Decreased Enzyme Activity Appear Y...om Nu Skin,Enterprises Inc. (NYSE: NUS ) presente...International Federation of Societies of Cosmetic ... correlation between levels of a,newly identified ...ce. The,study, conducted at Stanford University, d...
... Incidence of Late Stent Thrombosis Reported in CU... Trials, WASHINGTON and MENLO PARK, Calif., Oct....positive long-term follow-up,data from the CUSTOM ...efficacy of the Custom NX(R) drug eluting stent (D...ry disease. The CUSTOM clinical trials are,prospec...
...JOSE, Calif., Oct. 13 VNUS(R) Medical,Technologie...dical devices,for the minimally invasive treatment...at it plans to report its financial results for th...e close of market on October 29., VNUS plans to h....m. PT,/ 5:00 p.m. ET on October 29. This call wil...
Other Biology Technology:Nu Skin Scientists Correlate the Appearance of Aging With arNOX Free Radical Generator 2Nu Skin Scientists Correlate the Appearance of Aging With arNOX Free Radical Generator 3Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years 2Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years 3VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29 2
Mouse Anti-Polo like kinase Monoclonal Antibody, Unconjugated, Clone AZ24 from Abcam
...The dotLab System brings together two mature, well...raction and immobilized capture surfaces. This com...nique for the detection of molecular binding event...otein-specific capture molecules are immobilized o...
Heparin Clotting Assay Kit, HEPTEST from AMERICAN DIAGNOSTICA
Mun I (Mfe I) from Takara Mirus Bio
Biology Products: